申请人:Vyzkumny ustav pro farmacii a biochemii, statni podnik
公开号:US05175264A1
公开(公告)日:1992-12-29
This invention relates to 5-[4-[-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid (DISALAZINE) is provided as a new compound having anti-arthritic and immunomodulating properties. It can be produced via reaction of the diazonium salt of sulfadimidine reacted with salicylic acid and then acetylating the product anti-arthritic and immunomodulating properties.
本发明涉及5-[4-[-(4,6-二甲基-2-嘧啶基磺酰)苯偶氮]乙酰水杨酸(DISALAZINE),作为具有抗关节炎和免疫调节性质的新化合物。它可以通过将磺胺二甲嘧啶的重氮盐与水杨酸反应,然后乙酰化产物来制备。